Suzhou: Related Content
News •
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
• June 3, 2025, 11:09 AM ET (Globe and Mail)
Photos
Related Topics and References
Topics